| Value | ₹3.78 Cr |
|---|
BSE filing, NSE: JLHL. Summary written from the filing by ALFA Finder's alert engine.
Jupiter Life Line Hospitals Ltd: key numbers
- Share price
- ₹256.75
- Market cap
- ₹8,417 Cr
- Revenue (annual)
- ₹1,500 Cr
- Net profit (annual)
- ₹194.0 Cr
- P/E (TTM)
- 45.1×Sector 52.0×
- Promoter holding
- 40.91%+0.00% QoQ
- FII holding
- 9.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jupiter Life Line Hospitals Ltd
All →Jupiter Life Line Hospitals Earnings Call Transcript: Key Takeaways
Jupiter Lifeline reports strong growth with Q2 revenue of ₹456.5 Cr and EBITDA of ₹106.9 Cr. Management prioritizes asset ownership, recently acquiring the Pune South hospital land for ₹150 Cr.
Jupiter Life Line Hospitals Acquisition Worth ₹150 Cr
Jupiter Life Line Hospitals executed a sale agreement to acquire 11,452.07 sq m of land in Pune for Rs 150 Crore. The land is where its South Pune hospital project is under development.
- Value
- ₹150.0 Cr
Jupiter Life Line Hospitals Capacity Expansion: ₹0.01 Cr Investment
Jupiter Life Line Hospitals will hold 100% of newly incorporated subsidiary Holitti Private Limited, a healthcare services entity. The subscription is for paid-up capital of Rs 1,00,000, about Rs 0.01 Crore.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Merger & Restructuring Worth ₹0.01 Cr
Jupiter Life Line Hospitals will incorporate wholly owned subsidiary Holitti Private Limited for healthcare services, subscribing Rs 1 lakh. It will run laboratory and healthcare services.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Investor Presentation: Key Takeaways
Q2FY27 revenue Rs 436.3 cr (+15.8% YoY), EBITDA Rs 106.9 cr (23.4% margin), PAT Rs 56.4 cr (-1.7%) on Dombivli ramp-up, depreciation and finance costs. Bed capacity expanding from 1,700 to 2,900.
Jupiter Life Line Hospitals Q2 FY27 Results: Net Profit ₹56.4 Cr, Down 1.9% YoY
Jupiter Life Line Hospitals Ltd reported revenue from operations of ₹456.5 Cr (+16.0% YoY) and net profit of ₹56.4 Cr (-1.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹56.4 Cr · -1.9% YoY
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr